BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Neovasc Announces $65M Underwritten Offering of Units Consisting of Common Shares and Warrants To Purchase Common Shares and Concurrent Private Placement of Notes and Warrants

  The price of $1.46 per Unit represents the market price of Neovasc’s common shares as of the date of this news release.

  November 10, 2017

   · 

  24 min read
• Getinge’s Board of Directors Proposes a Distribution of the Patient Post-Acute Care Business Area to Getinge’s Shareholders

  The proposal includes the distribution of all shares in Arjo, where each share of series A in Getinge entitles to one share of series A in Arjo and each share of series B in Getinge entitles to one share of series B in Arjo.

  November 10, 2017

   · 

  12 min read
• Notice of Extraordinary General Meeting in Getinge AB

  The shareholders of Getinge are hereby invited to attend the EGM” to be held on Monday, December 4, 2017 at 16.00 CET, at Elite Park Avenue Hotel, Kungsportsavenyn 36-38 in Gothenburg, Sweden.

  November 10, 2017

   · 

  5 min read
• 

  Getinge Sets Revised Strategy, New Financial Targets Ahead of Arjo Listing

  Focus is on organic growth and Getinge foresees an organic market growth of 2-4% on average during 2017-2020 in the addressable market.

  November 10, 2017

   · 

  21 min read
• 

  Business

  Inotrem, Roche Diagnostics Ink Septic Shock R&D Deal

  It is Roche Diagnostics’ first collaboration agreement with a startup biotech company.

  November 10, 2017

   · 

  2 min read
• Business

  Medivir Appoints Christina Herder as Executive VP Strategic Business Development

  Christina will report to CEO Christine Lind and will join Medivir’s executive management team.

  November 10, 2017

   · 

  2 min read
• Biotech Bay

  SentreHEART Announces Participation at American Heart Association Scientific Sessions 2017

  SentreHEART, the manufacturer of the LARIAT Suture Delivery Device (LARIAT) will be participating in the American Heart Association (AHA) Scientific Sessions 2017 in Anaheim, California November 11-15, 2017.

  November 10, 2017

   · 

  2 min read
• Drug Development

  Infinity Pharma Reports IPI-549 Clinical and Translational Data From Completed Monotherapy Dose-Escalation Component of Phase I/Ib Clinical Study in Patients With Advanced Solid Tumors at SITC Annual Meeting

  These data from the recently completed monotherapy dose-escalation component of the Phase I/Ib study demonstrated that IPI-549 dosed once daily (QD) was well tolerated and clinically active.

  November 10, 2017

   · 

  11 min read
• Drug Development

  Alexo Therapeutics Presents Preliminary Results From ALX148 Phase I Clinical Trial in Patients with Advanced Solid Tumors and Lymphoma

  Preliminary results from the single agent portion of the trial (NCT03013218) showed that ALX148 is generally well tolerated in patients with advanced malignancy, with no dose-dependent impact on normal blood cells.

  November 10, 2017

   · 

  3 min read
• Quotient Sciences Launches as the New Global Identity for Quotient Clinical

  Quotient Clinical announces its renaming to Quotient Sciences (Quotient), following the acquisitions of Co-Formulate, QS Pharma and SeaView Research.

  November 10, 2017

   · 

  2 min read